Ascentage Pharma Group International (ASPHF)
USD 2.69
(0.0%)
USD 2.69
(0.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 1.06 Billion CNY | 2.56% |
| 2022 | 1.03 Billion CNY | 16.0% |
| 2021 | 894.41 Million CNY | 32.62% |
| 2020 | 674.42 Million CNY | 13.33% |
| 2019 | 595.1 Million CNY | 79.98% |
| 2018 | 330.65 Million CNY | 141.36% |
| 2017 | 136.99 Million CNY | 12.27% |
| 2016 | 122.02 Million CNY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 Q3 | 39.93 Million USD | 21.39% |
| 2023 Q4 | 41.08 Million USD | 2.86% |
| 2023 Q1 | 34.76 Million USD | -13.27% |
| 2023 FY | 1.06 Billion CNY | 2.56% |
| 2023 Q2 | 32.9 Million USD | -5.35% |
| 2022 Q4 | 40.08 Million USD | 3.16% |
| 2022 Q2 | 71.38 Million USD | 0.0% |
| 2022 FY | 1.03 Billion CNY | 16.0% |
| 2022 Q3 | 38.85 Million USD | -45.57% |
| 2021 Q2 | 58.33 Million USD | 0.0% |
| 2021 FY | 894.41 Million CNY | 32.62% |
| 2021 Q4 | 85.65 Million USD | 0.0% |
| 2020 FY | 674.42 Million CNY | 13.33% |
| 2020 Q2 | 42.62 Million USD | 0.0% |
| 2020 Q4 | 54.31 Million USD | 0.0% |
| 2019 Q2 | 35.44 Million USD | 0.0% |
| 2019 Q4 | 50.11 Million USD | 0.0% |
| 2019 FY | 595.1 Million CNY | 79.98% |
| 2018 FY | 330.65 Million CNY | 141.36% |
| 2017 FY | 136.99 Million CNY | 12.27% |
| 2016 FY | 122.02 Million CNY | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| RegeneRx Biopharmaceuticals, Inc. | 1.47 Million USD | -71857.773% |
| CSL Limited | 3.44 Billion USD | 69.148% |
| Eiger BioPharmaceuticals, Inc. | 86.78 Million USD | -1126.107% |
| Nanobac Pharmaceuticals, Incorporated | 4.91 Million USD | -21536.759% |
| Institute of Biomedical Research Corp. | 261.72 Thousand USD | -406461.442% |
| Evofem Biosciences, Inc. | 29.55 Million USD | -3500.572% |
| Santhera Pharmaceuticals Holding AG | 37.25 Million USD | -2756.148% |
| Propanc Biopharma, Inc. | 1.5 Million USD | -70748.772% |
| Mesoblast Limited | 5.9 Million USD | -17929.092% |
| Marizyme, Inc. | 19.23 Million USD | -5430.594% |
| Genus plc | 147.7 Million USD | -620.431% |
| VioQuest Pharmaceuticals, Inc. | 8.77 Million USD | -12020.385% |
| CNBX Pharmaceuticals Inc. | 1.34 Million USD | -79217.28% |
| Nymox Pharmaceutical Corporation | 8.33 Million USD | -12660.247% |
| ContraFect Corporation | 56.88 Million USD | -1770.444% |
| PsyBio Therapeutics Corp. | 4.4 Million USD | -24035.998% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| IMV Inc. | 37.7 Million USD | -2721.796% |
| AXIM Biotechnologies, Inc. | 2.79 Million USD | -38034.081% |
| MultiCell Technologies, Inc. | 567.42 USD | -187528890.871% |
| Accustem Sciences Inc. | 3.74 Million USD | -28302.509% |
| RVL Pharmaceuticals plc | 85.94 Million USD | -1138.091% |
| EV Biologics, Inc. | 531.96 Thousand USD | -199928.761% |
| Q BioMed Inc. | 3.43 Million USD | -30862.822% |
| Emmaus Life Sciences, Inc. | 24.71 Million USD | -4205.389% |
| Mosaic ImmunoEngineering Inc. | 2.62 Million USD | -40397.358% |
| Biomind Labs Inc. | 994.18 Thousand USD | -106930.403% |
| Oncotelic Therapeutics, Inc. | 6.71 Million USD | -15739.158% |
| Skye Bioscience, Inc. | 13.54 Million USD | -7754.387% |
| SQZ Biotechnologies Company | 85.61 Million USD | -1142.805% |
| THC Farmaceuticals, Inc. | -25 Thousand USD | 4256408.0% |
| Arch Therapeutics, Inc. | 5.04 Million USD | -21004.08% |
| Intellipharmaceutics International Inc. | 2.91 Million USD | -36388.04% |
| Acro Biomedical Co., Ltd. | 16.01 Million USD | -6546.229% |
| Neon Bloom, Inc. | 389.56 Thousand USD | -273044.217% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Pharming Group N.V. | 225.49 Million USD | -371.893% |
| Therapeutic Solutions International, Inc. | 2.04 Million USD | -51839.005% |
| Curative Biotechnology, Inc. | 1.83 Million USD | -57884.845% |
| GB Sciences, Inc. | 1.42 Million USD | -74808.149% |
| Alpha Cognition Inc. | 9.7 Million USD | -10863.535% |
| argenx SE | 1.53 Billion USD | 30.613% |
| HST Global, Inc. | 140.9 Thousand USD | -755062.625% |
| Halberd Corporation | 74.84 Thousand USD | -1421664.517% |
| Enzolytics Inc. | 2.17 Million USD | -48721.912% |
| Resverlogix Corp. | 12.71 Million USD | -8270.65% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| Nuo Therapeutics, Inc. | 3.65 Million USD | -29047.149% |
| MetaStat, Inc. | - USD | -Infinity% |
| Northwest Biotherapeutics, Inc. | 57.44 Million USD | -1752.502% |
| American Oriental Bioengineering, Inc. | 99.33 Million USD | -971.253% |
| Enzon Pharmaceuticals, Inc. | 1.04 Million USD | -101823.084% |
| Provectus Biopharmaceuticals, Inc. | 1.75 Million USD | -60369.984% |
| Endonovo Therapeutics, Inc. | 2.4 Million USD | -44145.58% |
| GlobeStar Therapeutics Corporation | 1.86 Million USD | -56974.347% |
| RespireRx Pharmaceuticals Inc. | 1.57 Million USD | -67274.15% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | 3.4 Million USD | -31150.619% |
| AVAX Technologies, Inc. | 7.31 Million USD | -14455.931% |
| ONE Bio Corp. | 6.44 Million USD | -16412.955% |
| Zenith Capital Corp. | 8.94 Million USD | -11798.435% |
| Genscript Biotech Corporation | 825.34 Million USD | -28.925% |
| Ember Therapeutics, Inc. | 17.42 Thousand USD | -6107913.317% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | 2.45 Million USD | -43237.663% |
| WPD Pharmaceuticals Inc. | 171.5 Thousand USD | -620320.503% |
| Cotinga Pharmaceuticals Inc. | 1.92 Million USD | -55294.538% |
| Wesana Health Holdings Inc. | 1.12 Million USD | -94492.19% |
| Agentix Corp. | 1.37 Million USD | -77470.428% |
| Adynxx, Inc. | - USD | -Infinity% |
| Kadimastem Ltd | 2.41 Million USD | -44050.521% |
| Helix BioMedix, Inc. | 1.97 Million USD | -53858.35% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Capstone Therapeutics Corp. | 10.86 Million USD | -9691.819% |
| BioStem Technologies, Inc. | 22.97 Million USD | -4531.496% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Reve Technologies, Inc. | 181.48 Thousand USD | -586216.775% |
| Burzynski Research Institute, Inc. | 1.33 Million USD | -79580.418% |
| LadRx Corporation | 3.81 Million USD | -27815.408% |
| Cell Source, Inc. | 4.32 Million USD | -24500.968% |
| ProtoKinetix, Incorporated | 415.47 Thousand USD | -256008.492% |
| Regen BioPharma, Inc. | 923.51 Thousand USD | -115120.951% |
| Regen BioPharma, Inc. | 923.51 Thousand USD | -115120.951% |
| NovAccess Global Inc. | 2.46 Million USD | -43036.607% |
| Affymax, Inc. | 39.38 Million USD | -2601.663% |
| Itoco Inc. | 919.14 Thousand USD | -115668.384% |
| Rasna Therapeutics, Inc. | 4.23 Million USD | -25005.547% |
| Pathfinder Cell Therapy, Inc. | 1.11 Million USD | -94991.778% |
| CytoDyn Inc. | 18.05 Million USD | -5792.552% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | 25.16 Thousand USD | -4227628.555% |
| NanoSphere Health Sciences Inc. | 220.07 Thousand USD | -483399.941% |
| Qrons Inc. | 643.67 Thousand USD | -165212.261% |
| Alseres Pharmaceuticals, Inc. | 1.41 Million USD | -74845.978% |
| SYBLEU INC | 160.87 Thousand USD | -661326.813% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| Nascent Biotech, Inc. | 2.22 Million USD | -47619.047% |
| Rebus Holdings, Inc. | 664 Thousand USD | -160152.56% |
| ImmunoCellular Therapeutics, Ltd. | 1.81 Million USD | -58484.225% |
| Mobile Lads Corp. | 554.54 Thousand USD | -191782.549% |
| International Stem Cell Corporation | 5.27 Million USD | -20087.384% |
| Bioxytran, Inc. | 3.82 Million USD | -27754.347% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | 52.64 Thousand USD | -2021246.073% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | 20.34 Thousand USD | -5230578.858% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 36.26 Million USD | -2834.09% |
| Adhera Therapeutics, Inc. | 1.61 Million USD | -65664.957% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | 735.83 Thousand USD | -144508.098% |
| Innovation Pharmaceuticals Inc. | 3.11 Million USD | -34103.697% |
| Neutra Corp. | 243.82 Thousand USD | -436317.29% |
| Windtree Therapeutics, Inc. | 17.45 Million USD | -5995.417% |
| PureTech Health plc | 144.59 Million USD | -635.891% |
| Coeptis Therapeutics, Inc. | 20.48 Million USD | -5093.181% |
| IXICO plc | 4.7 Million USD | -22506.267% |
| IntelGenx Technologies Corp. | 8.79 Million USD | -11995.908% |
| Gelesis Holdings, Inc. | 117.74 Million USD | -803.69% |
| CSL Limited | 3.89 Billion USD | 72.667% |
| Cellectis S.A. | 97.32 Million USD | -993.38% |